Workflow
Ascendis Pharma(ASND)
icon
Search documents
Ascendis Pharma(ASND) - 2021 Q3 - Earnings Call Transcript
2021-11-11 05:13
Ascendis Pharma A/S (ASND) Q3 2021 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Scott Smith - Senior Vice President and CFO Jan Mikkelsen - President and CEO Jesper Hoiland - Global Chief Commercial Officer Dr. Dana Pizzuti - Head, Development Operations and CMO Dr. Juha Punnonen - Head, Oncology Conference Call Participants Jessica Fye - J.P. Morgan Michelle Gilson - Canaccord Genuity Josh Schimmer - Evercore Alethia Young - Cantor Joori Park - SVB Leerink Operator Good day an ...
Ascendis Pharma(ASND) - 2020 Q3 - Earnings Call Transcript
2020-11-12 04:56
Ascendis Pharma A/S (ASND) Q3 2020 Earnings Conference Call November 11, 2020 4:30 PM ET Company Participants Scott Smith – Senior Vice President and Chief Financial Officer Jan Mikkelsen – President and Chief Executive Officer Mark Bach – Head-Clinical Development and Medical Affairs for Endocrinology Rare Diseases Jesper Høiland – Global Chief Commercial Officer Dana Pizzuti – Head-Development Operations Conference Call Participants Jessica Fye – JPMorgan Michelle Gilson – Canaccord Genuity Andrew Anido – ...
Ascendis Pharma(ASND) - 2020 Q2 - Earnings Call Transcript
2020-08-28 03:48
Ascendis Pharma A/S (ASND) Q2 2020 Earnings Conference Call August 27, 2020 4:30 PM ET Company Participants Scott Smith - CFO & SVP Jan Mikkelsen - President & CEO Dana Pizzuti - SVP, Development Operations Conference Call Participants Michelle Gilson - Canaccord Genuity Joori Park - SVB Leerink Joshua Schimmer - Evercore ISI Jessica Fye - JPMorgan Chase & Co. James Birchenough - Wells Fargo Securities Tazeen Ahmad - Bank of America Merrill Lynch Alethia Young - Cantor Fitzgerald & Co. Trevor Allred - Oppen ...
Ascendis Pharma (ASND) Investor Presentation - Slideshow
2020-08-11 19:36
ascendis pharma Ascendis Pharma A/S Cautionary Note On Forward-Looking Statements This presentation contains forward-looking statements. All statements other than statements of historical facts contained in this presentation, such as statements regarding our future results of operations and financial position, including our business strategy, prospective products, availability of funding, clinical trial results, product approvals and regulatory pathways, collaborations, licensing or other arrangements, the ...
Ascendis Pharma(ASND) - 2020 Q1 - Earnings Call Transcript
2020-05-20 10:09
Ascendis Pharma A/S (ASND) Q1 2020 Earnings Conference Call May 19, 2020 4:30 PM ET Company Participants Scott Smith - Senior Vice President and Chief Financial Officer Jan Mikkelsen - Chief Executive Officer Dana Pizzuti - Head, Development Operations Juha Punnonen - Head, Oncology Conference Call Participants Tazeen Ahmad - Bank of America Michelle Gilson - Canaccord David Lebowitz - Morgan Stanley Josh Schimmer - Evercore ISI Alethia Young - Cantor Fitzgerald Jim Birchenough - Wells Fargo Tiago Fauth - C ...
Ascendis Pharma(ASND) - 2019 Q4 - Annual Report
2020-04-03 01:19
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTI ...
Ascendis Pharma(ASND) - 2019 Q4 - Earnings Call Transcript
2020-04-02 08:35
Ascendis Pharma A/S (ASND) Q4 2019 Earnings Conference Call April 1, 2020 4:30 PM ET Company Participants Scott Smith - Senior Vice President and Chief Financial Officer Jan Mikkelsen - President and Chief Executive Officer Tom Larson - Chief Commercial Officer Juha Punnonen - Head, Oncology Dana Pizzuti - Head, Development Operations Conference Call Participants Jessica Fye - JPMorgan Tazeen Ahmad - Bank of America Michelle Gilson - Canaccord Genuity David Lebowitz - Morgan Stanley Jim Birchenough - Wells ...
Ascendis Pharma(ASND) - 2019 Q3 - Earnings Call Transcript
2019-11-19 02:25
Ascendis Pharma A/S (ASND) Q3 2019 Earnings Conference Call November 15, 2019 4:30 PM ET Company Participants Scott Smith - SVP and CFO Jan Mikkelsen - President and CEO Juha Punnonen - Head of Oncology Dana Pizzuti - Head of Development Operations Conference Call Participants Jessica Fye - JP Morgan Alethia Young - Cantor Fitzgerald Tazeen Ahmad - Bank of America Merrill Lynch David Lebowitz - Morgan Stanley Michelle Gilson - Canaccord Liana Moussatos - Wedbush Securities Josh Schimmer - Evercore ISI Josep ...